B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisition

  • 📰 BurnabyNOW_News
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 77%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

Deal includes US$15M upfront cash, US$42.5M in shares and potential US$24.5M bonus

A West Coast life sciences firm known for whipping up medical isotopes has whipped up a sizeable asking price for its sale.

Its goal is to address a global shortage of medical isotopes, which are used in diagnosing cancer and cardiac conditions. The global supply of medical isotopes previously relied on production from a nuclear reactor in Chalk River, Ont., which produced a large quantity of a parent isotope that decayed over time to form the medical isotope.That opened the door for ARTMS to use research from Triumf for commercial ventures.

Telix CEO Christian Behrenbruch described ARTMS as a “trailblazer” in the field of next generation cyclotron-based isotope production systens.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 14. in CA
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Canada Canada Latest News, Canada Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

B.C. medical isotope ‘trailblazer’ ARTMS fetches US$82M in Telix acquisitionDeal includes US$15M upfront cash, US$42.5M in shares and potential US$24.5M bonus
Source: PGCitizen - 🏆 65. / 51 Read more »